Kia ora

 

Thank you for taking the time to write to Hon Chris Hipkins, Minister for
COVID-19 Response, Minister of Education, Minister for the Public Sector
and Leader of the House.

We are receiving a significant amount of correspondence at the moment and,
although your email will be carefully considered and noted, it is not
possible to respond to each individual email. However, please note that
this is an automatic response and we will endeavour to respond to your
individual queries as soon as we can.

You can find the latest information and guidance about Alert Levels at
[1]https://covid19.govt.nz/alert-levels-and...
The locations of interest are set out
at [2]https://www.health.govt.nz/our-work/dise...
encourage anyone who has been at one of the locations of interest at the
time specified to self-isolate and call Healthline on 0800 358 5453. You
can find the nearest testing centre to you
at [3]https://www.healthpoint.co.nz/covid-19/.

We appreciate that this is a challenging time. If you need to talk, you
can call or text 1737 at any time. Mental health and wellbeing resources
are also available
at [4]https://www.health.govt.nz/our-work/dise...
about the financial support available to individuals and businesses can be
found at [5]https://covid19.govt.nz/business-and-mon....

We also understand that there are several other aspects to the response
that are very important to people. You can find more information about:

o Managed Isolation and Quarantine (MIQ)
at [6]https://www.miq.govt.nz/, including how to request an emergency
allocation
at [7]https://www.miq.govt.nz/travel-to-new-ze...
make a complaint or request a review of your application by
emailing [8]https://www.miq.govt.nz/about/contact-us....
o Travel with Australia
at [9]https://covid19.govt.nz/travel/quarantin...
you are in Australia, please register
at [10]https://www.safetravel.govt.nz/ and if it is an emergency,
contact the Consulate on +64 99 20 20 20.
o Vaccines at [11]https://covid19.govt.nz/covid-19-vaccines/, including
how to book your vaccine
at [12]https://bookmyvaccine.covid19.health.nz/... by calling 0800 28
29 26.
o Vaccine data and statistics
at [13]https://www.health.govt.nz/our-work/dise...
Medsafe’s vaccine safety monitoring reports
at [14]https://www.medsafe.govt.nz/COVID-19/vac...
o The Government’s plan to reconnect New Zealand with the rest of the
world
at [16]https://covid19.govt.nz/reconnecting-new....

Please remember to take care, and be kind. We have beaten COVID-19 before,
and we can do it again.

Ngā mihi,

Office of Hon Chris Hipkins

Minister for COVID-19 Response | Minister of Education | Minister for the
Public Sector | Leader of the House | MP for Remutaka

--------------------------------------------------------------------------

References

Visible links
1. https://covid19.govt.nz/alert-levels-and...
2. https://www.health.govt.nz/our-work/dise...
3. https://www.healthpoint.co.nz/covid-19/
4. https://www.health.govt.nz/our-work/dise...
5. https://covid19.govt.nz/business-and-mon...
6. https://www.miq.govt.nz/
7. https://www.miq.govt.nz/travel-to-new-ze...
8. https://www.miq.govt.nz/about/contact-us...
9. https://covid19.govt.nz/travel/quarantin...
10. https://www.safetravel.govt.nz/
11. https://covid19.govt.nz/covid-19-vaccines/
12. https://bookmyvaccine.covid19.health.nz/
13. https://www.health.govt.nz/our-work/dise...
14. https://www.medsafe.govt.nz/COVID-19/vac...
15. file:///C:/Users/TasolaM/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/556O8F80/Updated%20Document1.docx
16. https://covid19.govt.nz/reconnecting-new...

hide quoted sections

Kia ora Chuck,
On behalf of Hon Chris Hipkins, Minister for COVID-19 Response, thank you
for your request under the Official Information Act 1982 (the Act). This
information appears to be more closely associated with the functions and
responsibilities of the Ministry of Health. Accordingly, I am transferring
your request to the Ministry under section 14(b)(ii) of the Act. You can
expect a response from the Ministry of Health in due course.

You have the right, under section 28 of the Act, to ask the Ombudsman to
review this decision to transfer your request for information.

 

Thank you again for taking the time to write.

Ngā mihi

 

[1]cid:image001.jpg@01D7B3B9.BED43960 Yuuki
Smithers |
(Acting)
Health
Private
Secretary

Office of
Hon Chris
Hipkins   

Minister
for
COVID-19
Response |
Minister
of
Education
| Minister
for the
Public
Service |
Leader of
the House

Parliament
Buildings,
Private
Bag 18041,
Wellington
6160, New
Zealand

-----Original Message-----
From: Chuck Schooner
[[2]mailto:[FOI #17816 email]]
Sent: Friday, 3 December 2021 9:58 AM
To: C Hipkins (MIN) <[3][Chris Hipkins request email]>
Subject: Official Information request - Vaccines for 7-11 Year Olds

Dear Chris Hipkins, Ashley Bloomfield, Chris James,

You are recently on record as saying they are assessing if this vaccine
should be given to 7-11 year olds.

Please provide all documentation confirming that the vaccine is safe for
7-11 year olds.
Please specifically provide a cost-benefit analysis to support jabs for
this age group.

At an FDA panel hearing an expert doctor stated that the Pfizer vaccine
"failed any reasonable risk-benefit calculus in connection with children. 
He went on to state that vaccinating this age group you are assigning
innocent kids and uninformed parents to a fate that will undoubtedly rob
some of them of their lives".

Please provide a generic email that I can send this Pfizer document too so
that Medsafe are fully informed when they decide to inflict this poison on
the next generation.

Can you please state who will ultimately be responsible for potentially
inflicting anyone of the following illnesses on children and why they
believe this is okay? The list below is partial only directly from a
Pfizer document.

1p36 deletion syndrome;2-Hydroxyglutaric aciduria;5'nucleotidase
increased;Acoustic neuritis;Acquired C1 inhibitor deficiency;Acquired
epidermolysis bullosa;Acquired epileptic aphasia;Acute cutaneous lupus
erythematosus;Acute disseminated encephalomyelitis;Acute encephalitis with
refractory, repetitive partial seizures;Acute febrile neutrophilic
dermatosis;Acute flaccid myelitis;Acute haemorrhagic
leukoencephalitis;Acute haemorrhagic oedema of infancy;Acute kidney
injury;Acute macular outer retinopathy;Acute motor axonal neuropathy;Acute
motor-sensory axonal neuropathy;Acute myocardial infarction;Acute
respiratory distress syndrome;Acute respiratory failure;Addison's
disease;Administration site thrombosis;Administration site
vasculitis;Adrenal thrombosis;Adverse event following
immunisation;Ageusia;Agranulocytosis;Air
embolism;Alanine aminotransferase abnormal;Alanine aminotransferase
increased;Alcoholic seizure;Allergic bronchopulmonary mycosis;Allergic
oedema;Alloimmune hepatitis;Alopecia areata;Alpers disease;Alveolar
proteinosis;Ammonia abnormal;Ammonia increased;Amniotic cavity
infection;Amygdalohippocampectomy;Amyloid
arthropathy;Amyloidosis;Amyloidosis senile;Anaphylactic
reaction;Anaphylactic shock;Anaphylactic transfusion
reaction;Anaphylactoid reaction;Anaphylactoid shock;Anaphylactoid syndrome
of pregnancy;Angioedema;Angiopathic neuropathy;Ankylosing
spondylitis;Anosmia;Antiacetylcholine receptor antibody
positive;Anti-actin antibody positive;Anti-aquaporin-4 antibody
positive;Anti-basal ganglia antibody positive;Anti-cyclic citrullinated
peptide antibody positive;Anti-epithelial antibody
positive;Anti-erythrocyte antibody positive;Anti-exosome complex antibody
positive;AntiGAD antibody negative;Anti-GAD antibody
positive;Anti-ganglioside antibody positive;Antigliadin antibody
positive;Anti-glomerular basement membrane antibody
positive;Anti-glomerular basement membrane disease;Anti-glycyl-tRNA
synthetase antibody positive;Anti-HLA antibody test positive;Anti-IA2
antibody positive;Anti-insulin antibody increased;Anti-insulin antibody
positive;Anti-insulin receptor antibody increased;Antiinsulin receptor
antibody positive;Anti-interferon antibody negative;Anti-interferon
antibody positive;Anti-islet cell antibody positive;Antimitochondrial
antibody positive;Anti-muscle specific kinase antibody
positive;Anti-myelin-associated glycoprotein antibodies
positive;Anti-myelin-associated glycoprotein associated
polyneuropathy;Antimyocardial antibody positive;Anti-neuronal antibody
positive;Antineutrophil cytoplasmic antibody increased;Antineutrophil
cytoplasmic antibody positive;Anti-neutrophil cytoplasmic antibody
positive vasculitis;Anti-NMDA antibody positive;Antinuclear antibody
increased;Antinuclear antibody positive;Antiphospholipid antibodies
positive;Antiphospholipid syndrome;Anti-platelet antibody
positive;Anti-prothro Can you confirm if you will ultimately be
responsible for the roll out in kids?
And if you are will you take any responsibility for potentially giving
children anyone of the following illnesses from a recently released Pfizer
document.  1p36 deletion syndrome;2-Hydroxyglutaric
aciduria;5'nucleotidase increased;Acoustic neuritis;Acquired C1 inhibitor
deficiency;Acquired epidermolysis bullosa;Acquired epileptic aphasia;Acute
cutaneous lupus erythematosus;Acute disseminated encephalomyelitis;Acute
encephalitis with refractory, repetitive partial seizures;Acute febrile
neutrophilic dermatosis;Acute flaccid myelitis;Acute haemorrhagic
leukoencephalitis;Acute haemorrhagic oedema of infancy;Acute kidney
injury;Acute macular outer retinopathy;Acute motor axonal neuropathy;Acute
motor-sensory axonal neuropathy;Acute myocardial infarction;Acute
respiratory distress syndrome;Acute respiratory failure;Addison's
disease;Administration site thrombosis;Administration site
vasculitis;Adrenal thrombosis;Adverse event following
immunisation;Ageusia;Agranulocytosis;Air
embolism;Alanine aminotransferase abnormal;Alanine aminotransferase
increased;Alcoholic seizure;Allergic bronchopulmonary mycosis;Allergic
oedema;Alloimmune hepatitis;Alopecia areata;Alpers disease;Alveolar
proteinosis;Ammonia abnormal;Ammonia increased;Amniotic cavity
infection;Amygdalohippocampectomy;Amyloid
arthropathy;Amyloidosis;Amyloidosis senile;Anaphylactic
reaction;Anaphylactic shock;Anaphylactic transfusion
reaction;Anaphylactoid reaction;Anaphylactoid shock;Anaphylactoid syndrome
of pregnancy;Angioedema;Angiopathic neuropathy;Ankylosing
spondylitis;Anosmia;Antiacetylcholine receptor antibody
positive;Anti-actin antibody positive;Anti-aquaporin-4 antibody
positive;Anti-basal ganglia antibody positive;Anti-cyclic citrullinated
peptide antibody positive;Anti-epithelial antibody
positive;Anti-erythrocyte antibody positive;Anti-exosome complex antibody
positive;AntiGAD antibody negative;Anti-GAD antibody
positive;Anti-ganglioside antibody positive;Antigliadin antibody
positive;Anti-glomerular basement membrane antibody
positive;Anti-glomerular basement membrane disease;Anti-glycyl-tRNA
synthetase antibody positive;Anti-HLA antibody test positive;Anti-IA2
antibody positive;Anti-insulin antibody increased;Anti-insulin antibody
positive;Anti-insulin receptor antibody increased;Antiinsulin receptor
antibody positive;Anti-interferon antibody negative;Anti-interferon
antibody positive;Anti-islet cell antibody positive;Antimitochondrial
antibody positive;Anti-muscle specific kinase antibody
positive;Anti-myelin-associated glycoprotein antibodies
positive;Anti-myelin-associated glycoprotein associated
polyneuropathy;Antimyocardial antibody positive;Anti-neuronal antibody
positive;Antineutrophil cytoplasmic antibody increased;Antineutrophil
cytoplasmic antibody positive;Anti-neutrophil cytoplasmic antibody
positive vasculitis;Anti-NMDA antibody positive;Antinuclear antibody
increased;Antinuclear antibody positive;Antiphospholipid antibodies
positive;Antiphospholipid syndrome;Anti-platelet antibody
positive;Anti-prothro.

Yours faithfully,

Chuck Schooner

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[4][FOI #17816 email]

Is [5][Chris Hipkins request email] the wrong address for Official
Information requests to Chris Hipkins? If so, please contact us using this
form:
[6]https://scanmail.trustwave.com/?c=15517&...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[7]https://scanmail.trustwave.com/?c=15517&...

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

-------------------------------------------------------------------

________________________________

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

--------------------------------------------------------------------------

References

Visible links
2. mailto:[FOI #17816 email]
3. mailto:[Chris Hipkins request email]
4. mailto:[FOI #17816 email]
5. mailto:[Chris Hipkins request email]
6. https://scanmail.trustwave.com/?c=15517&...
7. https://scanmail.trustwave.com/?c=15517&...

hide quoted sections

Kia ora Chuck,

 

Thank you for your request for official information which was transferred
from the Office of Hon Chris Hipkins, Minister for COVID-19 Response and
received by the Ministry of Health on 3 December 2021. The Ministry’s
reference number for your request is H202117069.

 

If you need to contact us at any stage about your request, please quote
this reference number in your correspondence. You requested:

 

“You are recently on record as saying they are assessing if this vaccine
should be given to 7-11 year olds.

Please provide all documentation confirming that the vaccine is safe for
7-11 year olds.
Please specifically provide a cost-benefit analysis to support jabs for
this age group.

At an FDA panel hearing an expert doctor stated that the Pfizer vaccine
"failed any reasonable risk-benefit calculus in connection with children. 
He went on to state that vaccinating this age group you are assigning
innocent kids and uninformed parents to a fate that will undoubtedly rob
some of them of their lives".

Please provide a generic email that I can send this Pfizer document too so
that Medsafe are fully informed when they decide to inflict this poison on
the next generation.

Can you please state who will ultimately be responsible for potentially
inflicting anyone of the following illnesses on children and why they
believe this is okay? The list below is partial only directly from a
Pfizer document.

1p36 deletion syndrome;2-Hydroxyglutaric aciduria;5'nucleotidase
increased;Acoustic neuritis;Acquired C1 inhibitor deficiency;Acquired
epidermolysis bullosa;Acquired epileptic aphasia;Acute cutaneous lupus
erythematosus;Acute disseminated encephalomyelitis;Acute encephalitis with
refractory, repetitive partial seizures;Acute febrile neutrophilic
dermatosis;Acute flaccid myelitis;Acute haemorrhagic
leukoencephalitis;Acute haemorrhagic oedema of infancy;Acute kidney
injury;Acute macular outer retinopathy;Acute motor axonal neuropathy;Acute
motor-sensory axonal neuropathy;Acute myocardial infarction;Acute
respiratory distress syndrome;Acute respiratory failure;Addison's
disease;Administration site thrombosis;Administration site
vasculitis;Adrenal thrombosis;Adverse event following
immunisation;Ageusia;Agranulocytosis;Air
embolism;Alanine aminotransferase abnormal;Alanine aminotransferase
increased;Alcoholic seizure;Allergic bronchopulmonary mycosis;Allergic
oedema;Alloimmune hepatitis;Alopecia areata;Alpers disease;Alveolar
proteinosis;Ammonia abnormal;Ammonia increased;Amniotic cavity
infection;Amygdalohippocampectomy;Amyloid
arthropathy;Amyloidosis;Amyloidosis senile;Anaphylactic
reaction;Anaphylactic shock;Anaphylactic transfusion
reaction;Anaphylactoid reaction;Anaphylactoid shock;Anaphylactoid syndrome
of pregnancy;Angioedema;Angiopathic neuropathy;Ankylosing
spondylitis;Anosmia;Antiacetylcholine receptor antibody
positive;Anti-actin antibody positive;Anti-aquaporin-4 antibody
positive;Anti-basal ganglia antibody positive;Anti-cyclic citrullinated
peptide antibody positive;Anti-epithelial antibody
positive;Anti-erythrocyte antibody positive;Anti-exosome complex antibody
positive;AntiGAD antibody negative;Anti-GAD antibody
positive;Anti-ganglioside antibody positive;Antigliadin antibody
positive;Anti-glomerular basement membrane antibody
positive;Anti-glomerular basement membrane disease;Anti-glycyl-tRNA
synthetase antibody positive;Anti-HLA antibody test positive;Anti-IA2
antibody positive;Anti-insulin antibody increased;Anti-insulin antibody
positive;Anti-insulin receptor antibody increased;Antiinsulin receptor
antibody positive;Anti-interferon antibody negative;Anti-interferon
antibody positive;Anti-islet cell antibody positive;Antimitochondrial
antibody positive;Anti-muscle specific kinase antibody
positive;Anti-myelin-associated glycoprotein antibodies
positive;Anti-myelin-associated glycoprotein associated
polyneuropathy;Antimyocardial antibody positive;Anti-neuronal antibody
positive;Antineutrophil cytoplasmic antibody increased;Antineutrophil
cytoplasmic antibody positive;Anti-neutrophil cytoplasmic antibody
positive vasculitis;Anti-NMDA antibody positive;Antinuclear antibody
increased;Antinuclear antibody positive;Antiphospholipid antibodies
positive;Antiphospholipid syndrome;Anti-platelet antibody
positive;Anti-prothro Can you confirm if you will ultimately be
responsible for the roll out in kids?
And if you are will you take any responsibility for potentially giving
children anyone of the following illnesses from a recently released Pfizer
document.  1p36 deletion syndrome;2-Hydroxyglutaric
aciduria;5'nucleotidase increased;Acoustic neuritis;Acquired C1 inhibitor
deficiency;Acquired epidermolysis bullosa;Acquired epileptic aphasia;Acute
cutaneous lupus erythematosus;Acute disseminated encephalomyelitis;Acute
encephalitis with refractory, repetitive partial seizures;Acute febrile
neutrophilic dermatosis;Acute flaccid myelitis;Acute haemorrhagic
leukoencephalitis;Acute haemorrhagic oedema of infancy;Acute kidney
injury;Acute macular outer retinopathy;Acute motor axonal neuropathy;Acute
motor-sensory axonal neuropathy;Acute myocardial infarction;Acute
respiratory distress syndrome;Acute respiratory failure;Addison's
disease;Administration site thrombosis;Administration site
vasculitis;Adrenal thrombosis;Adverse event following
immunisation;Ageusia;Agranulocytosis;Air
embolism;Alanine aminotransferase abnormal;Alanine aminotransferase
increased;Alcoholic seizure;Allergic bronchopulmonary mycosis;Allergic
oedema;Alloimmune hepatitis;Alopecia areata;Alpers disease;Alveolar
proteinosis;Ammonia abnormal;Ammonia increased;Amniotic cavity
infection;Amygdalohippocampectomy;Amyloid
arthropathy;Amyloidosis;Amyloidosis senile;Anaphylactic
reaction;Anaphylactic shock;Anaphylactic transfusion
reaction;Anaphylactoid reaction;Anaphylactoid shock;Anaphylactoid syndrome
of pregnancy;Angioedema;Angiopathic neuropathy;Ankylosing
spondylitis;Anosmia;Antiacetylcholine receptor antibody
positive;Anti-actin antibody positive;Anti-aquaporin-4 antibody
positive;Anti-basal ganglia antibody positive;Anti-cyclic citrullinated
peptide antibody positive;Anti-epithelial antibody
positive;Anti-erythrocyte antibody positive;Anti-exosome complex antibody
positive;AntiGAD antibody negative;Anti-GAD antibody
positive;Anti-ganglioside antibody positive;Antigliadin antibody
positive;Anti-glomerular basement membrane antibody
positive;Anti-glomerular basement membrane disease;Anti-glycyl-tRNA
synthetase antibody positive;Anti-HLA antibody test positive;Anti-IA2
antibody positive;Anti-insulin antibody increased;Anti-insulin antibody
positive;Anti-insulin receptor antibody increased;Antiinsulin receptor
antibody positive;Anti-interferon antibody negative;Anti-interferon
antibody positive;Anti-islet cell antibody positive;Antimitochondrial
antibody positive;Anti-muscle specific kinase antibody
positive;Anti-myelin-associated glycoprotein antibodies
positive;Anti-myelin-associated glycoprotein associated
polyneuropathy;Antimyocardial antibody positive;Anti-neuronal antibody
positive;Antineutrophil cytoplasmic antibody increased;Antineutrophil
cytoplasmic antibody positive;Anti-neutrophil cytoplasmic antibody
positive vasculitis;Anti-NMDA antibody positive;Antinuclear antibody
increased;Antinuclear antibody positive;Antiphospholipid antibodies
positive;Antiphospholipid syndrome;Anti-platelet antibody
positive;Anti-prothro.”

Please be advised that due dates for requests received from 29 November
2021 onwards take into account the following periods:

 

Christmas (25 December 2021)

Summer Holidays (25 December to 15 January)

New Year's Day (1 January 2022)

Day after News Year's Day (2 January 2022)

 

Your request has been logged and you can expect a reply no later than 21
January 2022 as required under the Official Information Act 1982.

 

Due to the COVID-19 global pandemic response, the Ministry is experiencing
significantly higher volumes of queries and requests for information. If
we are unable to respond to your request within this time frame, we will
notify you of an extension of that time frame.

 

If you have any queries related to this request, please do not hesitate to
get in touch.

 

Ngâ mihi

 

OIA Services

Government Services

Office of the Director-General

Ministry of Health

E: [1][email address]

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. mailto:[email address]

hide quoted sections



Kia ora 

 

Thank you for your email. The Ministry of Health is closed from Thursday
23 December 2021—Monday 10 January 2022. We will respond to your email
when the Ministry reopens. Thank you for your patience. 

 

OIA requests

Please note that under the Official information Act 1982, the days from 25
December 2021 to Saturday 15 January 2022 (inclusive), are not ‘working
days’ for the purposes of the law and therefore do not form part of the 20
working days required to respond.  For more information on this, please
visit the OIA calculator at: [1]ombudsman.parliament.nz/

 

COVID-19 information 

·    for information on the Government’s response to the COVID-19
pandemic, please go to [2]covid19.govt.nz 

·    for information about COVID-19 locations of interest:
[3]health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-health-advice-public/contact-tracing-covid-19/covid-19-contact-tracing-locations-interest

·    for information on COVID-19 testing sites:
[4]covid19.govt.nz/testing-and-tracing/covid-19-testing/where-to-get-tested/

·    for information on COVID-19 vaccination (including bookings) go to:
[5]health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-vaccines

·    for information on managed isolation, including exemptions from
managed isolation, please go to [6]miq.govt.nz 

 

Emergency services and health information 

·    if you are in an emergency situation, please dial 111 

·    if you require health advice or information, please
call Healthline free 24/7 on 0800 611 116. 

 

Mental health helplines 

If you require [7]mental health assistance please contact one of the
following free national helplines: 

·    1737: free text 24/7. Trained counsellors can offer support for
addiction issues, as well as advice on mental health 

·    the National Depression Helpline: free call 24/7 on 0800 111 757,
text 4202, or online at [8]depression.org.nz 

·    Lifeline: free call 24/7 on 0800 543 354 

·    Samaritans: free call on 0800 726 666. Confidential, non-religious,
and non-judgmental support

 

Ngā mihi 

OIA Services 

 

 

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. http://www.ombudsman.parliament.nz/
2. https://scanmail.trustwave.com/?c=15517&...
3. http://www.health.govt.nz/our-work/disea...
4. https://covid19.govt.nz/testing-and-trac...
5. http://www.health.govt.nz/our-work/disea...
6. https://scanmail.trustwave.com/?c=15517&...
7. http://mentalhealth.org.nz/
8. http://scanmail.trustwave.com/?c=15517&a...

hide quoted sections

Kia ora Chuck
Please find attached a response to your requests for official information.

Ngâ mihi 

 

OIA Services 

Office of the Director-General | Ministry of Health  

  

E: [1][email address]  

 

Do your bit to keep New Zealand COVID free; get vaccinated; wear a mask;
practice good hygiene (includes washing your hands often and coughing into
your elbow), sign using the NZ COVID Tracer app, if you’re unwell stay
home and get tested. 

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. mailto:[email address]

hide quoted sections